Cases & Deals

Data safety monitoring committee represented in U.S. investigations of drug trial

Clients Medical researchers

Jones Day represented members of a data safety monitoring committee for a controversial drug trial in connection with investigations by the U.S. Securities & Exchange Commission, Congress, the Department of Justice, and numerous state attorneys general.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.